FIELD: medicine.
SUBSTANCE: invention refers to medicine, oncology, and may be used for treating locally advanced oncological diseases in experiment. For this purpose, a malignant growth is exposed to infrared laser light in molecular oxygen absorption band. The exposure is performed in a pulse mode at power density specified to avoid thermal tissue coagulation and to provide generation of chemically active electron-excited oxygen in tissue. The exposure is preceded by introducing the photosensitiser tetrahydroporphyrin-tetra-n-toluene sulphonate at 5-15 mg/kg of animal model's body weight. Then in 0.5-2 hours, a parental tumour is exposed to interstitial laser. And 8-12 hours, the metastases are covered in the range of wave harmonics 690-762 nm or 1270 nm in a single dose at power density 200-300 J/cm2.
EFFECT: method provides higher clinical effectiveness by increasing a penetration depth of the water-soluble photosensitiser tetrahydroporphyrin-tetra-n-toluene sulphonate introduced immediately in the tumour tissue, tumour tissue regression ensured by a apoptosis reaction; enabled use of the method in veterinary science.
14 dwg
Title | Year | Author | Number |
---|---|---|---|
PHOTOSENSIBILISER AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2535097C1 |
METHOD FOR PHOTODYNAMIC THERAPY OF ONCOLOGICAL DISEASES | 2013 |
|
RU2537759C1 |
PREPARATION FOR PHOTODYNAMIC THERAPY | 1997 |
|
RU2146144C1 |
PHOTOSENSITISER FOR PHOTODYNAMIC THERAPY | 2012 |
|
RU2479585C1 |
PHOTOSENSITISER FOR PHOTODYNAMIC THERAPY | 2013 |
|
RU2549953C2 |
METHOD FOR PHOTODYNAMIC THERAPY OF MALIGNANT TUMOURS | 2016 |
|
RU2617090C1 |
METHOD OF LASER INHIBITION OF TUMOUR GROWTH AND ELIMINATION | 2006 |
|
RU2325200C2 |
METHOD FOR APPLYING PHOTODYNAMIC THERAPY OF MALIGNANT NEOPLASMS | 1997 |
|
RU2147249C1 |
METHOD FOR TREATING MALIGNANT NEOPLASMS BY APPLYING PHOTODYNAMIC THERAPY | 1998 |
|
RU2157268C2 |
METHOD OF PHOTODYNAMIC THERAPY OF TUMOURS | 2012 |
|
RU2519936C2 |
Authors
Dates
2012-04-10—Published
2010-07-15—Filed